28-December-2015

Retirement of Mr. R. Gopalakrishnan as non-executive director and vice chairman of the company

21-October-2015

Resignation of Prasad R. Menon as non-executive, non-independent director

20-October-2015

Appointment of Bhaskar Bhat as an additional director

20-October-2015

Appointment of John Mulhall as the chief financial officer and key managerial personnel of the company

01-April-2015

Resignation of Dr Vijay L Kelkar, non-executive independent director

01-October-2015

Retirement of PK Ghose, executive director and CFO

15-January-2016

Regulation 30 (5) of the listing regulations

25-February-2016

Intimation under regulation 30 of the SEBI (Listing obligations and disclosure requirements) regulations, 2015

27-February-2016

Intimation under regulation 30 of the SEBI

23-March-2016

Temporary shutdown of Babrala plant

30-March-2016

Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations - 30 March 2016

06-April-2016

Schedule of analyst / institutional investor meeting

11-April-2016

MoU with Sanjana Cryogenics Storage Ltd

10-May-2016

Babrala plant operations resumed

19-May-2016

Notice for board meeting - Q4 results

25-May-2016

lntimation of schedule of analyst / lnstitutional lnvestor meetinqs under the SEBI (Listino obliqations and disclosure requirements) requlations. 2015

28-May-2016

Regulation 29 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 (LODR) regulations

30-May-2016

Details of non-convertible debentures for the half year ended March 31, 2016

31-May-2016

Appointment of Dr Nirmalya Kumar as an additional director

07-June-2016

Intimation to the exchange pursuant to regulation 57(2) of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015

06-June-2016

Metahelix has entered into a joint venture with Mr Suresh Gobindram Vaswani

07-June-2016

Details of nonconvertible debentures for the half vear ended March 31, 2016

07-June-2016

Outcome of board meeting in accordance with the SEBI (Listing obliqations and disclosure requirements) regulations, 2015

09-June-2016

Intimation of schedule of analyst/ institutional investor meetings

15-June-2016

Intimation under Regulation 30 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015 (LODR) Regulations

04-August-2016

Board meeting notice for quarterly results 05 August 2016

23-August-2016

Intimation of schedule of analyst/ institutional investor meetings - 23 August 2016

31-August-2016

Investor meeting - 31 August 2016

06-September-2016

Crisil rating

12-September-2016

MoU with Sanjana cryogenics - 12 September 2016

12-September-2016

Eknath Kshirsagar retirement

12-September-2016

Investor call intimation - 12 September 2016

25-October-2016

Replacement of Mr Cyrus P Mistry as Chairman of Tata Sons Limited with Mr Ratan N. Tata as interim Chairman of Tata Sons Limited

28-October-2016

Review of credit rating - NCD of Rs250 crore

02-November-2016

Resignation of Dr Nirmalya Kumar, non-executive director

02-November-2016

NSE Email and Letter dated October 27, 2016 on News Clarification

02-November-2016

Analysts call announcement November 11, 2016

09-November-2016

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

11-November-2016

Resignation of Mr Bhaskar Bhat, non-executive, non independent director

11-November-2016

Disclosure under Regulation 30 of the SEBl (Listing obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')

17-November-2016

Analysts call announcement November 16, 2016

24-November-2016

Analysts call announcement November 21-22, 2016

24-November-2016

Outcome of the Board Meeting November 22, 2016

24-November-2016

Analysts call announcement November 25, 2016

28-November-2016

Notice of extraordinary general meeting - December 23, 2016

05-December-2016

Analysts call announcement December 5, 2016

15-December-2016

Notice of motion

16-December-2016

Representation of Mr Nusli N Wadia - Stock exchange letter

19-December-2016

Notice of motion number 3504

09-December-2016

Representation of Mr Cyrus P Mistry - Stock exchange letter

20-December-2016

Resignation of Mr Cyrus P Mistry as Director

24-December-2016

Proceedings and voting results of the extra general meeting - 23 December 2016

26-December-2016

Change in board of directors

29-December-2016

Credit ratings

17-January-2017

Credit Rating - Non-Convertible Debenture (NCD) of Rs. 250 crores

31-January-2017

Memorandum of understanding (MOU) with Government of Andhra Pradesh

31-January-2017

Board meeting notice for quarterly results - 08 February 2017

08-February-2017

Outcome of the Board Meeting - 08 February 2017

08-February-2017

Presentation for Analysts' call - 08 February 2017

08-February-2017

Press Release on Financial Results for the Q3 and nine months ended December 31, 2016

09-February-2017

Regulation 30 (1) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - Outcome of the Board Meeting - 08 February 2017

22-February-2017

SE Analyst Meet - Intimation of schedule of analyst

22-February-2017

SE Letter Haldia - Intimation under regulation 30 of the SEBI

02-March-2017

lnstitutional lnvestor Meetings uncler the SEBI Requlations, 2015

08-March-2017

Institutional Investor Meetings under the SEBI Requlations, 2015

14-March-2017

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015

15-March-2017

Institutional Investor Meetinqs under the SEBI (LODR) Requlations, 2015

23-March-2017

Institutional Investor Meetings under the SEBI Requlations, 2015

30-March-2017

IEPF Advertisement - for Transfer of Shares to Investor Education and Protection Fund (IEPF) Account

04-April-2017

Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015

07-April-2017

Newspaper Advertisement of Equity Shareholders Meeting

13-April-2017

List of Related party under SEBI (LODR) Regulations, 2015

10-May-2017

Board Meeting

10-May-2017

SE letter BTA Unnati Inorganics - Intimation under regulation 30 of the SEBI

11-May-2017

TCL NCLT Convened Meeting Proceedings and Voting Results 2017 BSE

26-May-2017

Outcome of board meeting in accordance with the SEBI (Listing obligations and disclosure requirements) regulations, 2015

26-May-2017

Submission of presentation made to Analysts / Investors

26-May-2017

Undertaking for the year ended 31st March, 2017 under Regulation 57 of the SEBI (Listing obligations and disclosure requirements) Regulations, 2015

26-May-2017

Details of Non-Convertible Debentures for the year ended March 31, 2017

26-May-2017

Audited results for the Press Release for the year ended March 31, 2017

30-May-2017

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

13-June-2017

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

27-June-2017

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

03-July-2017

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

05-July-2017

Certilication under Regulation 57(l) of the SEBI (LODR) Regulations' 2015

07-July-2017

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

27-July-2017

Regulation 29 (1) (a) of the SEBI (Listing Obligations and disclosure requirements) regulations, 2015 - regulations of the Board Meeting - 08 August 2017

03-August-2017

Regulation 30 of the SEBI, LODR 2015 - Unnati Inorganics Private Limited - Cancellation of Transaction

08-August-2017

Outcome of Board Meeting for Q1 Results of FY 2017-18

07-August-2017

Press Release for Q1 Results of FY 2017-18

07-August-2017

Analysts Presentation for Q1 Results of FY 2017-18

14-August-2017

Annual Report 2016-17 under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

07-September-2017

Analysts call - 12th September, 2017

13-September-2017

Proposed Sale of equity shares of Tata Global Beverages Limited

13-September-2017

Analysts call - 20th September, 2017

13-September-2017

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015

21-September-2017

Sale of equity shares of Tata Global Beverages Limited

20-September-2017

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

26-September-2017

Analysts call on 26th September, 2017

30-October-2017

lntimation of schedule of Analyst / lnstitutional lnvestor Meetings under the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015

01-November-2017

Newspaper publication of notice of meeting of board of directors - Navshakti

01-November-2017

Newspaper publication of notice of meeting of board of directors - Business Standard

06-November-2017

Intimation for Sale of Phosphatic Business

06-November-2017

Press Release for Sale of Phosphatic Fertilisers Business

13-November-2017

Press Release for Q2 Results dated 13.11.2017 of FY 2017-18

13-November-2017

Analysts Presentation for Q2 Results dated 13.11.2017 of FY 2017-18

13-November-2017

Outcome of Board Meeting dated 13.11.2017 for Q2 Results of FY 2017-18

13-November-2017

Certificate under Regulation 52(4) & 52(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2017.

14-November-2017

Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - English

14-November-2017

Newspaper Advertisement (Quarter and Half Year Ended Results September 30, 2017) - Marathi

24-November-2017

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

06-December-2017

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

08-December-2017

Sanction of Scheme of Arrangement for the transfer of the business of Urea and customized fertilisers located at Babrala, Uttar Pradesh to Yara Fertilisers India Private Limited by NCLT, Mumbai Bench, Mumbai

08-December-2017

Intimation of incorporation of new wholly owned subsidiary under Section 8 of the Companies Act, 2013

11-December-2017

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-December-2017

Compliance under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot Notice

13-December-2017

Compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Postal Ballot 2017

15-December-2017

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-January-2018

Completion of Sale and Transfer of Urea and Customized Fertilisers Business to Yara Fertilisers India Private Limited (“Yara”)

23-January-2018

Notice of Board Meeting - 6th February, 2018

04-February-2018

Outcome of Board Meeting dated 06.02.2018 for Q3 Results of FY 2017-18

05-February-2018

Press Release for Q3 Results dated 06.02.2018 of FY 2017-18

06-February-2018

Analysts Presentation for Q3 Results dated 06.02.2018 of FY 2017-18

14-February-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-February-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

26-February-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

28-February-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

23-March-2018

Stock Exchange Intimation under Regulation 30 - Appointment of Directors

26-March-2018

Intimation under Resolution 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015

27-March-2018

Intimation - Corrigendum to intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

03-April-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

09-April-2018

Regulation 30 as 'BTA with ASL'

24-April-2018

Notice of Board Meeting - 7th May, 2018

07-May-2018

Postponement of Board Meeting to be held on May 7, 2018

06-May-2018

Rescheduled Bord Meeting 6th May, 2018

08-May-2018

Notice for potponement of Board Meeting- English

08-May-2018

Notice for postponement of Board Meeting- Marathi

15-May-2018

Analysts' Call on Audited Financial Results for the year ended 31st March 2018

21-May-2018

Outcome of Board Meeting dated May 18, 2018 approving the Standalone and Consolidated Financial Results for FY 2017-18 and declaration of Dividend.

20-May-2018

Press Release dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18

19-May-2018

Intimation under Regulation 30 of SEBI Listing Regulations regarding re-appointment of Mr. R. Mukundan as Managing Director and CEO.

19-May-2018

Undertaking for the year ended March 31, 2018 pursuant to Regulation 57 of SEBI Listing Regulations

19-May-2018

Details of Non-convertible Debentures for the year ended March 31, 2018 pursuant to Regulation 52(4) and 52(5) of SEBI Listing Regulations

19-May-2018

Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (NSE)

19-May-2018

Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations (BSE)

Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18

19-May-2018

Analysts/Investor Presentation dated May 18, 2018 for Standalone and Consolidated Financial Results for FY 2017-18

21-May-2018

Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018) - Marathi

21-May-2018

Newspaper Advertisement (Financial Results for the Year Ended March 31, 2018 - English

29-May-2018

Intimation under Regulation 50(1) and 60(2) of SEBI Listing Regulations of Record Date and Payment of Interest Date

30-May-2018

Intimation under Regulation 30 of SEBI Listing Regulations for transfer of Ordinary Shares of the Company to Investor Education and Protection Fund

01-June-2018

Intimation under Regulation 30 of SEBI Listing Regulations for sale and disposal of Phosphatic Fertilisers business and the Trading business to IRC Agrochemicals Private Limited effective June 1, 2018

05-June-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

18-June-2018

Completion of acquisition of precipitated silica business of Allied Silica Limited

19-June-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

29-June-2018

Notice of 79th Annual General Meeting

03-July-2018

Intimation under Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for notice of 79th AGM and Book Closure dates

03-July-2018

Intimation under Reg. 57(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Payment of Annual Interest to Debentureholders

18-July-2018

Webcast of 79th Annual General Meeting

20-July-2018

Credit Ratings

26-July-2018

Intimation of change in Segment Reporting of Tata Chemicals Limited under Regulation 30 of the SEBI Listing Regulations

26-July-2018

Outcome of the 79th Annual General Meeting

02-August-2018

Notice of Board Meeting - August 13, 2018

02-August-2018

Newspaper publication of notice of meeting of Board of Directors - Marathi

02-August-2018

Newspaper publication of notice of meeting of Board of Directors - English

13-August-2018

Presentation on the Analyst Call

13-August-2018

lntimation under Regulations 30 and 33 of SEBI (Listinq Obligations and Disclosure Requirements) Regulations. 2015

13-August-2018

Press Release on the Financial Results for the quarter ended June 30, 2018

14-August-2018

Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - English

13-August-2018

Newspaper Advertisement (Financial Results for first quarter ended June 30, 2018) - Marathi

31-August-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

08-September-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

13-September-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

25-September-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17-October-2018

Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)

22-October-2018

Newspaper publication of notice of meeting of Board of Directors (02.11.2018) - English & Marathi

24-October-2018

MoU signed by the Company with CSIR – CECRI (Central Electrochemical Research Institute), Karaikudi

02-November-2018

lntimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

02-November-2018

Press Release on the Financial Results for the quarter ended September 30, 2018

05-November-2018

Non-convertible Debentures - Compliance of Regulations 52(4), 52(5) and 52(7) of SEBI Listing Regulations for the half year ended September 30, 2018

06-November-2018

Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - Marathi

06-November-2018

Newspaper Advertisement (Financial Results for quarter and half year ended September 30, 2018) - English

28-November-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

26-November-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

30-November-2018

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

04-December-2018

Intimation of letter sent to shareholders holding shares in physical form for updating PAN and Bank details and converting their holdings into Demat

17-January-2019

Intimation under Regulation 29 (1) (a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)

18-January-2019

Newspaper publication of notice of meeting of Board of Directors (05.02.2019) - English & Marathi

05-February-2019

Outcome of Board Meeting held on February 5, 2019 - Intimation under Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

05-February-2019

Presentation on the Analyst Call

05-February-2019

Press Release on the Financial Results for the quarter ended December 31, 2018

07-February-2019

Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - English

06-February-2019

Newspaper Advertisement (Financial Results for quarter ended December 31, 2018) - Marathi

11-February-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

21-February-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

25-February-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

14-March-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

18-March-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

22-March-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17-April-2019

Intimation of the Board Meeting to be held on May 3, 2019

19-April-2019

Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - English

18-April-2019

Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2019 - Marathi

03-May-2019

Outcome of Board Meeting dated May 3, 2019: Approval of Standalone and Consolidated Financial Results for FY 2018-19

03-May-2019

Outcome of Board Meeting dated May 3, 2019: Recommendation of Dividend for FY 2018 -19

03-May-2019

Analysts/Investor Presentation dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19

03-May-2019

Press Release dated May 3, 2019 for Standalone and Consolidated Financial Results for FY 2018-19

03-May-2019

Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations

08-May-2019

Newspaper Advertisement (Financial Results for quarter and year ended March 31, 2019) - Marathi

08-May-2019

Newspaper Advertisement (Financial Results for the quarter and year ended March 31, 2019) - English

08-May-2019

Annual Secretarial Compliance Report for the Financial Year ended March 31, 2019

16-May-2019

Outcome of the Board Meeting held on May 15, 2019: Intimation of Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited and their respective shareholders and creditors

16-May-2019

Intimation of Analyst / Investor Call held to discuss the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited

16-May-2019

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Newspaper Advertisement for Notice of transfer of shares to Investor Education and Protection Fund

17-May-2019

Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Related Party Transactions for the half year ended March 31, 2019

28-May-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

31-May-2019

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Company’s Registrar and Share Transfer Agent update

01-June-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

04-June-2019

Intimation under Regulation 50(1) and 60(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Record Date and Payment of Principal, Interest and Redemption Date

05-June-2019

Notice and Explanatory Statement of the 80th Annual General Meeting

12-June-2019

Annual Report for FY 2018-19 under Regulation 34(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

13-June-2019

Newspaper publication of notice of the 80th Annual General Meeting of the Company

26-June-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

04-July-2019

Intimation under Regulation 57(1) of the Listing Regulations of payment of Principal along with Annual Interest to the Debentureholders of 2500 – 10% Rated Taxable Unsecured Redeemable Non-Convertible Debentures

09-July-2019

Outcome of the 80th Annual General Meeting

09-July-2019

Intimation under Regulation 30 of the Listing Regulations for re-appointment of Ms. Vibha Paul Rishi as an Independent Director

18-July-2019

Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by Brickwork Ratings India Private Limited

24-July-2019

Intimation of the Board Meeting to be held on August 8, 2019

25-July-2019

Redemption of Non-Convertible Debentures (‘NCDs’) on due date and subsequent withdrawal of Credit Rating by CARE Ratings Limited

26-July-2019

Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - Marathi

26-July-2019

Newspaper publication of notice of the meeting of Board of Directors to be held on August 8, 2019 - English

08-August-2019

Outcome of the Board Meeting dated August 8, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the quarter ended June 30, 2019

08-August-2019

Press Release dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019

08-August-2019

Analysts/Investor Presentation dated August 8, 2019 for Audited Standalone and Unaudited Consolidated Financial Results for first quarter ended June 30, 2019

09-August-2019

Intimation of Appointment of Director under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015

13-August-2019

Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - Marathi

13-August-2019

Newspaper Advertisement (Financial Results for the first quarter ended June 30, 2019) - English

21-August-2019

Cessation of Mr. Nasser Munjee and Dr. Y. S. P. Thorat as Independent Directors of the Company

27-August-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

30-August-2019

Intimation of reappointment of Ms Vibha Paul Rishi as an Independent Director of the Company under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirement Regulations, 2015

21-August-2019

Appointment of Dr. C V Natraj as an Independent Director of the Company

27-September-2019

Notice of the Meeting of Equity Shareholders of Tata Chemicals Limited convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench

01-October-2019

Newspaper Advertisement of Notice of the Meeting of the Equity Shareholders of Tata Chemicals Limited to be convened pursuant to the directions of the Hon'ble National Company Law Tribunal, Mumbai Bench

15-October-2019

Appointment of Mr. K.B.S. Anand as an Independent Director of the Company

19-October-2019

Stock Exchange Intimation of the Board Meeting of the Company to be held on October 30, 2019

22-October-2019

Newspaper publication of Notice of the Meeting of the Board of Directors to be held on October 30, 2019 - English

22-October-2019

Newspaper publication of notice of the Meeting of the Board of Directors to be held on October 30, 2019 - Marathi

30-October-2019

Outcome of the Board Meeting dated October 30, 2019: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the second quarter and half year ended September 30, 2019

31-October-2019

Outcome of the National Company Law Tribunal Convened Meeting of Tata Chemicals Limited held on Wednesday, October 30, 2019

31-October-2019

Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - English

31-October-2019

Newspaper Advertisement (Financial Results for the second quarter and half year ended September 30, 2019) - Marathi

06-November-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

13-December-2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-December-2019

Intimation under Regulation 30 read with Schedule III of SEBI LODR - Acquisition of remaining 25% interest in Tata Chemicals (Soda Ash) Partners Holding

06-January-2020

Disclosure received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

03-January-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

10-January-2020

Intimation of sanction of Scheme of Arrangement by NCLT Mumbai and Kolkata Bench

16-January-2020

Stock Exchange Intimation of the Board Meeting of the Company to be held on February 3, 2020

22-January-2020

Newspaper publication of notice of the meeting of Board of Directors to be held on February 3, 2020 - English and Marathi

24-January-2020

Rescheduling of Analyst' call on the financial results for the third quarter and nine months ended December 31, 2019

03-February-2020

Outcome of the Board Meeting dated February 3, 2020: Approval of Unaudited Consolidated and Audited Standalone Financial Statements for the third quarter and nine months ended December 31, 2019

03-February-2020

Press Release dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for third quarter and nine months ended December 31, 2019

03-February-2020

Analysts/Investor Presentation dated February 3, 2020 for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019

06-February-2020

Stock exchange intimation of Newspaper Publication for Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2019

07-February-2020

Intimation for Effective Date of the Scheme of Arrangement amongst Tata Chemicals Limited and Tata Global Beverages Limited

10-February-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-February-2020

Disclosure dated February 10, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

14-February-2020

Intimation of the Record Date pursuant to Regulation 42 of SEBI LODR Regulations

17-February-2020

Intimation of Newspaper advertisement for notice of Record Date

20-February-2020

Disclosures dated February 18 and 19, 2020 received under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015: Inter-se transfers

28-February-2020

Disclosure dated February 27, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

06-March-2020

Disclosure dated March 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

12-March-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

18-March-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-March-2020

Purchase of shares by Mr. N. Chandrasekaran

20-March-2020

Clarification on the disclosures submitted under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 on February 28, 2020 and March 5, 2020

20-March-2020

Disclosure dated March 17, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

23-March-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

25-March-2020

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Shutdown/ scale down of manufacturing operations at the Company’s plants due to outbreak of Coronavirus (COVID-19)

24-April-2020

Intimation for sanction of Scheme of Merger by Absorption of Bio Energy Venture - 1 (Mauritius) Pvt. Ltd by Tata Chemicals Limited

11-May-2020

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) - Resuming of manufacturing operations at the Company’s plants

12-May-2020

Stock Exchange Intimation of the Board Meeting of the Company to be held on May 15, 2020

15-May-2020

Outcome of the Board Meeting dated May 15, 2020: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2020 and recommendation of Dividend

15-May-2020

Rescheduling of Analysts' Call and Presentation to be made at the rescheduled call

17-May-2020

Cost of Acquisition of shares of Tata Chemicals Limited and Tata Consumer Products Limited (erstwhile Tata Global Beverage Limited) as per the provisions of Sections 49(2C) and 49(2D) of the Income Tax Act, 1961

16-May-2020

Press Release dated May 15, 2020 for Audited Standalone and Audited Consolidated Financial Results for the year ended ended March 31, 2020

22-May-2020

Intimation of Book Closure Date pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - 81st Annual General Meeting of the Company

21-May-2020

Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

22-May-2020

Date of 81st Annual General Meeting of the Company

26-May-2020

Intimation of Schedule of Analyst/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

28-May-2020

Communication to Shareholders - Intimation on Tax Deduction on Dividend

03-June-2020

Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders

05-June-2020

Corrigendum to the Audited Consolidated Financial Results for the year ended March 31, 2020

08-June-2020

Disclosure regarding impact of Covid-19 pandemic on the Company’s operations

08-June-2020

Disclosure of Related Party Transactions for the half year ended March 31, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

09-June-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

14-June-2020

Newspaper Advertisement- Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

14-June-2020

Submission of Annual Secretarial Compliance Report for the Financial Year 2019-20

13-June-2020

Effective Date of Scheme of Merger by Absorption under Section 234 read with Section 230 to Section 232 of the Companies Act, 2013 of Bio Energy Venture – 1 (Mauritius) Pvt. Ltd (Transferor Company) by Tata Chemicals Limited (Transferee Company) and their respective shareholders

14-June-2020

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 81st Annual General Meeting

14-June-2020

Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2019-20

23-June-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

23-June-2020

Newspaper Advertisement for transfer of shares to IEPF Account

29-June-2020

Confirmation by Tata Chemicals on non-applicability of SEBI Circular dated November 26, 2018 w.r.t. Large Corporates

29-June-2020

Annual Disclosure by Tata Chemicals Limited being identified as a Large Corporate as on March 31, 2019

06-July-2020

Disclosure regarding impact of Covid-19 pandemic on the Company’s operations - Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020

09-July-2020

Outcome of the 81st Annual General Meeting

20-July-2020

Stock Exchange Intimation of the Board Meeting of the Company to be held on July 31, 2020

21-July-2020

Newspaper publication of notice of the meeting of Board of Directors to be held on July 31, 2020 - English and Marathi

31-July-2020

Outcome of the Board Meeting dated July 31, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020.

31-July-2020

Analysts/Investors Presentation dated July 31, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2020

01-August-2020

Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter ended June 30, 2020

31-July-2020

Press Release on Financial Results for the first quarter ended June 30, 2020

03-September-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

18-September-2020

Intimation for appointment of Mr. Rajiv Dube as an Independent Director

01-October-2020

Disclosure dated September 25, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

01-October-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

09-October-2020

Shifting of Investor Service Centers of Registrar and Transfer Agent of the Company

06-October-2020

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2020

19-October-2020

Stock Exchange Intimation for the Board Meeting of the Company to be held on October 29, 2020

20-October-2020

Newspaper publication of notice of the meeting of Board of Directors to be held on October 29, 2020 - English and Marathi

29-October-2020

Outcome of the Board Meeting dated October 29, 2020: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020

29-October-2020

Press Release on Financial Results for the quarter and half year ended September 30, 2020

29-October-2020

Analysts/Investors Presentation dated October 29, 2020 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2020

30-October-2020

Stock Exchange Intimation for Newspaper Publication of Financial Results for the quarter and half year ended September 30, 2020

05-November-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

20-November-2020

Disclosure of Related Party Transactions for the half year ended September 30, 2020 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

24-November-2020

Stock exchange intimation for appointment of Mr. N. Chandrasekaran as an additional Director and Chairman of the Company

24-November-2020

Stock exchange intimation for resignation of Mr. Bhaskar Bhat as a Director of the Company

30-November-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

03-December-2020

Disclosures dated December 1 and December 3, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

08-December-2020

Disclosure dated December 7, 2020 received from Tata Sons Private Limited under Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015

11-December-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

30-December-2020

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

01-January-2021

Stock exchange intimation for withdrawal of Tata Chemicals (Soda Ash) Partners from the American Natural Soda Ash Corporation (ANSAC)

14-January-2021

Clarification/confirmation on the news item appearing in Economic Times captioned ‘Tata Chemicals in advanced talks to buy debt-laden Archean unit’

18-January-2021

Stock Exchange Intimation for the Board Meeting of the Company to be held on January 28, 2021

19-January-2021

Newspaper publication of notice of the meeting of Board of Directors to be held on January 28, 2021 - English and Marathi

21-January-2021

Outcome of the Board Meeting dated January 28, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020

28-January-2021

Press Release on Financial Results for the third quarter and nine months ended December 31, 2020

28-January-2021

Analysts/Investors Presentation dated January 28, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2020

29-January-2021

Stock Exchange Intimation for Newspaper Publication of Financial Results for the third quarter and nine months ended December 31, 2020

15-February-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-February-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

23-February-2021

Advertisement – Transfer of equity shares pursuant SEBI Circular dated November 6, 2018 - February 23, 2021

26-February-2021

Change in Key Managerial Personnel (Chief Financial Officer) of the Company

26-February-2021

Shifting of registered office of Registrar and Transfer Agent of the Company

02-March-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-March-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-March-2021

Newspaper Advertisement - Intimating change of the registered office of Registrar and Transfer Agent of the Company - TSR Darashaw Consultants Private Limited

01-April-2021

Disclosure under Regulation 30 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)

09-April-2021

Intimation in terms of SEBI Circular No. SEBI/HO/MIRSD/DOS3/CIR/P/2018/139 dated November 6, 2018 pertaining to transfer of securities in physical mode

27-April-2021

Stock Exchange Intimation of the Board Meeting of the Company to be held on May 3, 2021

27-April-2021

Newspaper publication of notice of the meeting of Board of Directors to be held on May 3, 2021 - English and Marathi

03-May-2021

Outcome of the Board Meeting dated May 3, 2021: Approval of Audited Consolidated and Audited Standalone Financial Statements for the year ended March 31, 2021 and recommendation of Dividend

03-May-2021

Outcome of Board Meeting dated May 3, 2021: Recommendation of Dividend for FY 2020-21

03-May-2021

Intimation of Book Closure pursuant to Regulation 42 of SEBI Listing Regulations

03-May-2021

Press Release dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021

03-May-2021

Analysts/Investor Presentation dated May 3, 2021 for Audited Standalone and Consolidated Financial Results for FY 2020-21

04-May-2021

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2021

17-May-2021

Disclosure of Related Party Transactions for the half year ended March 31, 2021 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

17-May-2021

Annual Secretarial Compliance Report for the Financial Year ended March 31, 2021

24-May-2021

Communication to Shareholders - Intimation on Tax Deduction on Dividend

28-May-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

05-June-2021

Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 82nd Annual General Meeting'

09-June-2021

Reaffirmation of Credit Rating by CRISIL Ratings upon reduction in quantum of rated amount of Commercial Paper

10-June-2021

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Notice and Explanatory Statement of the 82nd Annual General Meeting

10-June-2021

Intimation under Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Integrated Annual Report for FY 2020-21

11-June-2021

Intimation under Regulation 30 - Newspaper Advertisement 'Notice of the 82nd Annual General Meeting, E-Voting and Book Closure'

08-June-2021

Affirmation of Credit Rating by Moody’s Investors Service

14-June-2021

Intimation under Regulation 30 Newspaper Advertisement for Transfer of Shares to IEPF on June 12, 2021

18-June-2021

Stock Exchange Intimation for corrigendum to the Integrated Annual Report FY 2020-21

02-July-2021

Reaffirmation of Credit Rating by CARE Ratings

05-July-2021

Outcome of the 82nd Annual General Meeting

27-July-2021

Stock Exchange Intimation of the Board Meeting of the Company to be held on August 5, 2021

03-August-2021

Stock Exchange intimation providing details of Analysts’ Call on the Audited Standalone and Unaudited Consolidated Financial Results for the first quarter ended June 30, 2021

05-August-2021

Outcome of the Board Meeting dated August 5, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021

05-August-2021

Press Release on Financial Results for the first quarter ended June 30, 2021

05-August-2021

Analysts/Investors Presentation dated August 05, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2021

05-August-2021

Quarter ended June 2021: Q1 FY22

06-August-2021

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2021

07-August-2021

Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021

11-August-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

14-August-2021

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2021

26-August-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

14-September-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17-September-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

13-October-2021

Reduction in rated amount and reaffirmation of credit rating by CARE Ratings

19-October-2021

Stock Exchange Intimation of the Board Meeting of the Company to be held on October 27, 2021

27-October-2021

Outcome of the Board Meeting dated October 27, 2021: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021

27-October-2021

Press Release on Financial Results for the second quarter and half-year ended September 30, 2021

27-October-2021

Analysts/Investors Presentation dated October 27, 2021 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half-year ended September 30, 2021

28-October-2021

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the second quarter and half year ended September 30, 2021

29-October-2021

Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2021

08-November-2021

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended September 30, 2021

25-November-2021

Disclosure of Related Party Transactions for the half year ended September 30, 2021 pursuant to Regulation 23(9) of the SEBI Listing Regulations

30-November-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

01-December-2021

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

31-January-2022

Stock Exchange Intimation of the Board Meeting of the Company to be held on February 10, 2022

10-February-2022

Outcome of the Board Meeting dated February 10, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021

10-February-2022

Analysts/Investors Presentation dated February 10, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine-months ended December 31, 2021

10-February-2022

Press Release on Financial Results for the third quarter and nine-months ended December 31, 2021

11-February-2022

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2021

12-February-2022

Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021

Related Party Transactions

29-April-2022

Press Release on Financial Results for the fourth quarter and year ended March 31, 2022

29-April-2022

Outcome of the Board Meeting dated April 29, 2022: Recommendation of Dividend for FY 2021-22

29-April-2022

Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

30-April-2022

Stock Exchange Intimation for Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022

30-April-2022

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Consolidated Financial Results for the fourth quarter and year ended March 31, 2022

03-May-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

03-May-2022

Corrigendum to the Note 5 of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2022

06-May-2022

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended March 31, 2022

09-May-2022

Company's reply to the clarification sought by the exchange

16-May-2022

Stock Exchange Intimation for Annual Disclosure for Fund raising by issuance of Debt Securities by Large Entities

29-April-2022

Stock Exchange Intimation for Initial Disclosure for Fund raising by issuance of Debt Securities by Large Entities

16-May-2022

Disclosure of Related Party Transactions for the half year ended March 31, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations

21-May-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

26-May-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

26-May-2022

Stock Exchange Intimation of Communication to Shareholders - Tax Deduction on Dividend

30-May-2022

Intimation under Regulation 30 - Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)

30-May-2022

Annual Secretarial Compliance Report for the Financial Year ended March 31, 2022

16-February-2022

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-February-2022

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2021

22-February-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

09-March-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

16-March-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17-March-2022

Affirmation of Credit Rating by Fitch Ratings

23-March-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

29-March-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

28-March-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

20-April-2022

Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2022

27-April-2022

Change in name of Company’s Registrar and Transfer Agent (RTA)

29-April-2022

Outcome of the Board Meeting dated April 29, 2022: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022

29-April-2022

Re-appointment of Statutory Auditor of the Company

29-April-2022

Analysts/Investors Presentation dated April 29, 2022 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2022

08-June-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

08-June-2022

Reaffirmation of Credit Rating by CRISIL Ratings

08-June-2022

Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 83rd Annual General Meeting'

08-June-2022

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

10-June-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

13-June-2022

Intimation for Business Responsibility & Sustainability Report

11-June-2022

Intimation for Notice and Explanatory Statement of the 83rd Annual General Meeting

11-June-2022

Intimation for Integrated Annual Report for FY 2021-22

18-June-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

27-June-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

28-June-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

07-July-2022

Outcome of the 83rd Annual General Meeting

13-July-2022

Reaffirmation of Credit Rating by CARE Ratings

29-July-2022

Stock Exchange Intimation for the Board Meeting of the Company to be held on August 9, 2022

09-August-2022

Outcome of the Board Meeting dated August 9, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022

09-August-2022

Press Release on Financial Results for the first quarter ended June 30, 2022

09-August-2022

Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022

09-August-2022

Analyst/Investors Presentation dated August 9, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the first quarter ended June 30, 2022

10-August-2022

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the First Quarter ended June 30, 2022

10-August-2022

Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the quarter ended June 30, 2022

12-August-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

18-August-2022

Stock Exhange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 2022

18-August-2022

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

30-August-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-September-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-September-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17-October-2022

Stock Exchange Intimation for the Board Meeting of the Company to be held on October 27, 2022

27-October-2022

Outcome of the Board Meeting dated October 27, 2022: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022

27-October-2022

Press Release on Financial Results for the second quarter and half year ended September 30, 2022

27-October-2022

Analyst/Investors Presentation dated October 27, 2022 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the second quarter and half year ended September 30, 2022

28-October-2022

Stock Exchange Intimation for Newspaper Publication of Audited Standalone and Unaudited Consolidated Financial Results for the Second Quarter and Half Year ended September 30, 2022

28-October-2022

Stock Exchange Intimation for Audio Recording of Analyst/Investors Call pertaining to Financial Results for the second quarter and half year ended September 30, 2022

02-November-2022

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2022

14-November-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

22-November-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

28-November-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

05-December-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-December-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-December-2022

Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

20-January-2023

Stock Exchange Intimation for the Board Meeting of the Company to be held on February 1, 2023

01-February-2023

Outcome of the Board Meeting dated February 1, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022

01-February-2023

Press Release on Financial Results for the third quarter and nine months ended December 31, 2022

01-February-2023

Analyst/Investors Presentation dated February 1, 2023 for Audited Standalone and Unaudited Consolidated Financial Results of the Company for the third quarter and nine months ended December 31, 2022

01-February-2023

Re-appointment of Ms. Padmini Khare Kaicker as Independent Director and Mr. Zarir Langrana as Executive Director

02-February-2023

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022

02-February-2023

Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2022

07-February-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

02-February-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

08-February-2023

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022

08-February-2023

Corrigendum to our letter dated February 1, 2023 intimating the re-appointment of Directors

14-February-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

16-February-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

21-February-2023

Notice of Postal Ballot for re-appointment of Directors

22-February-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

22-February-2023

Newspaper Advertisement – Notice of Postal Ballot and E-Voting Information

24-February-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

01-March-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

03-March-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

08-March-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

13-March-2023

Stock Exchange intimation - FITCH Ratings revises Tata Chemicals’ Outlook to Positive

20-March-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

20-March-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

23-March-2023

Voting Results of Postal Ballot through remote e-Voting

21-April-2023

Stock Exchange Intimation for the Board Meeting of the Company to be held on May 3, 2023

03-May-2023

Analyst/Investors Presentation dated May 3, 2023 for Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023

03-May-2023

Press Release on Financial Results for the fourth quarter and year ended March 31, 2023

03-May-2023

Outcome of the Board Meeting dated May 3, 2023: Recommendation of Dividend for FY 2022-23

03-May-2023

Outcome of the Board Meeting dated May 3, 2023: Approval of Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and year ended March 31, 2023

04-May-2023

Newspaper Advertisement - Audited Standalone and Consolidated Financial Statements for the fourth quarter and year ended March 31, 2023

04-May-2023

Audio Recording of the Analysts/Investors Call pertaining to the Financial Results for the fourth quarter and year ended March 31, 2023

16-May-2023

Annual General Meeting of the Company and Intimation of Book Closure pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

23-May-2023

Re-appointment of Director of the Company

24-May-2023

Communication to Shareholders - Intimation on Tax Deduction on Dividend

24-May-2023

Intimation to the holders of physical securities to furnish PAN, shareholders KYC details and Nomination as per SEBI Circular dated March 16, 2023

25-May-2023

Submission of Annual Secretarial Compliance Report for the Financial Year 2022-23

25-May-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

26-May-2023

Intimation under Regulation 30 Newspaper Advertisement - 'Public Notice - 84th Annual General Meeting and Book Closure'

30-May-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

02-June-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

02-June-2023

Business Responsibility and Sustainability Report for the Financial Year 2022-23

02-June-2023

Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure) Regulations, 2015

02-June-2023

Notice of the 84th Annual General Meeting (‘AGM’) of the Company for FY 2022- 23

02-June-2023

Re-affirmation of Credit Rating by CRISIL

02-June-2023

Intimation regarding simplification of the holding structure of the US operations of Tata Chemicals Limited

03-June-2023

Newspaper Advertisement-Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

07-June-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

09-June-2023

Newspaper Advertisement for Transfer of Shares to Investor Education and Protection Fund (IEPF)

26-June-2023

Outcome of the 84th Annual General Meeting

07-July-2023

Affirmation of Credit Rating by Moody’s

18-July-2023

Increase of shareholding in Rallis India Limited

25-July-2023

Intimation for the Board Meeting of the Company to be held on August 7, 2023

02-August-2023

Intimation of Re-scheduled Analyst / Institutional Investor Meeting

07-August-2023

Outcome of the Board Meeting dated August 7, 2023: Approval of Audited Standalone and Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2023

07-August-2023

Press Release on Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023

07-August-2023

Analyst/Investors Presentation dated August 7, 2023 for Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023

08-August-2023

Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the quarter ended June 30, 2023

08-August-2023

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023

14-August-2023

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

16-August-2023

Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2023

17-August-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-September-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

13-September-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

04-October-2023

Reaffirmation of Credit Rating by CARE Ratings

23-October-2023

Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on November 10, 2023

23-October-2023

Intimation for the Board Meeting of the Company to be held on November 10, 2023

01-November-2023

Intimation under Regulation 30 of SEBI Listing Regulations – update on pending litigations

10-November-2023

Outcome of the Board Meeting dated November 10, 2023: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half year ended September 30, 2023

10-November-2023

Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2023

10-November-2023

Analyst/Investors Presentation dated November 10, 2023 for Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30 2023

10-November-2023

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023

11-November-2023

Newspaper Advertisement - Unaudited Consolidated and Standalone Financial Results for the second quarter and half yer ended September 30, 2023

17-November-2023

Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2023

23-November-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

25-November-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

27-November-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

07-December-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

11-December-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

14-December-2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

30-December-2023

Merger of Registrar & Transfer Agent i.e. TSR Consultants Private Limited with Link Intime India Private Limited

02-January-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

23-January-2024

Intimation for the Board Meeting of the Company to be held on February 5, 2024

23-January-2024

Intimation of Analyst’s Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to be held on February 5, 2024

27-January-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

30-January-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

05-February-2024

Outcome of the Board Meeting dated February 5, 2024: Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2023

05-February-2024

Press Release on Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023

05-February-2024

Analyst/Investors Presentation dated February 5, 2024 for Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023

05-February-2024

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023

06-February-2024

Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the third quarter and nine months ended December 31, 2023

07-February-2024

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-February-2024

Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2023

14-February-2024

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

17-February-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

24-February-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

26-February-2024

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

28-February-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

29-February-2024

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

01-March-2024

FITCH Ratings affirms Tata Chemicals Limited’s credit rating at BB+ & revises Outlook to Stable

18-March-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

21-March-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

20-April-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-April-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

19-April-2024

Stock Exchange Intimation of the Board Meeting of the Company to be held on April 29, 2024

19-April-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

23-April-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

25-April-2024

Stock Exchange Intimation for Update on the Board Meeting to be held on April 29, 2024

26-April-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

27-April-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

28-April-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

29-April-2024

Re-appointment of Directors of the Company

29-April-2024

Outcome of the Board Meeting dated April 29, 2024: Approval of Audited Consolidated and Standalone Financial Results of the Company for the fourth quarter and year ended March 31, 2024

29-April-2024

Outcome of the Board Meeting dated April 29, 2024: Recommendation of Dividend for Financial Year 2023-24

29-April-2024

Press Release - Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2024

29-April-2024

Analysts/ Investors presentation dated April 29, 2024 for the Audited Consolidated and Standalone financial results of the Company for the quarter and financial year ended March 31, 2024

29-April-2024

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter and year ended March 31, 2024

30-April-2024

Newspaper Advertisement - Audited Consolidated and Standalone Financial Results for the quarter and financial year ended March 31, 2024

01-May-2024

Change in the Senior Management Personnel of the Company

30-April-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

01-May-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

03-May-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

31-March-2024

Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and financial year ended March 31, 2024

18-May-2024

Reminder letter to shareholders and Advertisement for transfer of Shares to Investor Education and Protection Fund (IEPF)

18-May-2024

Communication to Shareholders - Intimation on Tax Deduction on Dividend

20-May-2024

Intimation to the holders of physical securities to furnish PAN, KYC details and Nomination as per SEBI Circular dated May 17, 2023

21-May-2024

Intimation of date of 85th Annual General Meeting and Record Date for payment of Dividend

24-May-2024

Intimation under Regulation 30- Newspaper Advertisement- Public Notice of 85th Annual General Meeting and Record Date

29-May-2024

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

31-May-2024

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

03-June-2024

Notice of the 85th Annual General Meeting (‘AGM’) of the Company for FY 2023- 24

03-June-2024

Integrated Annual Report under Regulation 34(1) of the SEBI (Listing Obligations and Disclosure) Regulations, 2015 (‘Listing Regulations’)

03-June-2024

Business Responsibility and Sustainability Report for the Financial Year 2023-24

06-June-2024

Newspaper Advertisement - Disclosure under Regulations 30 and 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

06-June-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-June-2024

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

25-June-2024

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

27-June-2024

Outcome of the 85th Annual General Meeting

29-June-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

20-July-2024

Stock Exchange Intimation of the Board Meeting of the Company to be held on August 5, 2024

20-July-2024

Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

05-August-2024

Outcome of the Board Meeting dated August 5, 2024- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024

05-August-2024

Press Release- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024

05-August-2024

Analysts/Investors presentation dated August 5, 2024 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2024

05-August-2024

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the quarter ended June 30, 2024

06-August-2024

Newspaper Advertisement- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended June 30, 2024

08-August-2024

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

09-August-2024

Outcome of the Meeting of Internal Committee – Issue of Non-Convertible Debentures aggregating to 1,700 crore rupees

09-August-2024

Outcome of the Meeting of Internal Committee – Issue of Non-Convertible Debentures aggregating to ? 1,700 crore

12-August-2024

Transcript of Analysts/Investors Call pertaining to the Financial Results for the first quarter ended June 30, 2024

20-August-2024

Outcome of the Meeting of the Internal Committee - Allotment of Non-Convertible Debentures (NCDs) on Private Placement basis

21-August-2024

Intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

22-August-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

22-August-2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

23-August-2024

Intimation of Re-scheduled Analyst/Institutional Investor Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

28-August-2024

Intimation of under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

31-August-2024

Intimation of under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

31-August-2024

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

10-September-2024

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

27-September-2024

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

08-October-2024

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

08-October-2024

Intimation under Regulation 55 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

10-October-2024

Intimation of the Board Meeting of the Company to be held on October 17, 2024

10-October-2024

Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

11-October-2024

Specifications related to ISINs for debt securities for the half year ended September 30, 2024

17-October-2024

Outcome of the Board Meeting dated October 17, 2024- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024

17-October-2024

Press Release- Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024

17-October-2024

Analysts/Investors presentation dated October 17, 2024 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the second quarter and half-year ended September 30, 2024

17-October-2024

Statement of utilisation of issue proceeds of NCDs

17-October-2024

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2024

18-October-2024

Newspaper Advertisement - Unaudited Consolidated and Audited Standalone Financial Results for the second quarter and half year ended September 30, 2024

18-October-2024

Intimation of Re-scheduled Analyst/Institutional Investor Meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

24-October-2024

Transcript of Analysts/Investors Call pertaining to the Financial Results for the second quarter and half year ended September 30, 2024

06-November-2024

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

11-November-2024

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-November-2024

Intimation under Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

28-November-2024

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-December-2024

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

12-December-2024

Intimation of Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

31-December-2024

Analysts/Investors presentation dated February 3, 2025 for Unaudited Consolidated and Audited Standalone Financial Results of the Company for the third quarter and nine months ended December 31, 2024

09-January-2025

Investor Grievance Redressal Policy

12-December-2024

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)

28-January-2025

Intimation of the Board Meeting of the Company to be held on February 3, 2025 Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

29-January-2025

Completion of tenure of an Independent Director

04-February-2025

Integrated Filing (Financial) for the third quarter and nine months ended December 31, 2024

04-February-2025

Shareholding Pattern as on December 31, 2024

12-December-2024

Analyst call

19-December-2024

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

02-January-2025

Intimation regarding change in name of Company’s Registrar and Transfer Agent (RTA)

07-January-2025

Schedule of Analysts/Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

25-April-2025

Shareholding Pattern as on March 31, 2025

11-February-2025

Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2024

14-February-2025

Integrated Filing (Governance) for the quarter ended December 31, 2024

19-February-2025

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

27-February-2025

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

12-March-2025

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

13-March-2025

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

01-April-2025

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19-February-2025

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

08-April-2025

Specifications related to ISINs for debt securities for the half-year ended March 31, 2025

21-April-2025

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

21-April-2025

Intimation under Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

21-April-2025

Intimation of change in contact details of MUFG Intime India Private Limited, Registrar and Transfer Agent of the Company

25-April-2025

Intimation regarding Centralized Database for corporate bonds/ debentures

30-April-2025

Intimation of the Board Meeting of the Company to be held on May 7, 2025

30-April-2025

Intimation of Analysts/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

02-May-2025

Reminder letter to shareholders and advertisement for transfer of shares to Investor Education and Protection fund

18-July-2025

Intimation of the Board Meeting of the Company to be held on July 25, 2025

18-July-2025

Intimation of Analysts’/Investors Call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

25-July-2025

Outcome of the Board Meeting dated July 25, 2025- Approval of Unaudited Consolidated and Audited Standalone Financial Results of the Company for the first quarter ended on June 30, 2025